elucidate the mechanisms or related processes of resistance to CDDP. We previously established a CDDP-resistant subline, PC-7/CDDP, from a human lung cancer cell line, PC-7, in order to elucidate the mechanisms of resistance to CDDP and to assist in developing strategies to circumvent CDDP resistance (Hong et al., 1988; Bungo et al., 1990; . We demonstrated that PC-7/CDDP cells do not exhibit cross-resistance or collateral sensitivity to adriamycin, daunomycin, mitomycin C, bleomycin, etoposide, or vindesine. In contrast, PC-7/CDDP cells exhibited collateral sensitivity to FUra . Determination of the mechanisms of such enhanced drug sensitivity may reveal the factors that contribute to cellular sensitivity to FUra and their relation to the mechanisms of CDDP resistance. Therefore, we searched for the possible mechanisms associated with the collateral sensitivity to FUra in PC-7/ CDDP cells.
The mechanism of action of FUra is complex and cytotoxicity appears to depend upon the cell type being studied. FUra is known to exert its cytotoxic effect by at least two mechanisms: incorporation of FUra into RNA and inhibition of thymidylate synthase (TS) (Chabner, 1981; Heidelberger et al., 1983) . FUra is anabolised to the ribonucleotide, FUTP. FUTP is incorporated into RNA, which may alter RNA function. FUra is also anabolised to the deoxyribomonophosphate, FdUMP. In the presence of methylenetetrahydrofolate cofactor, FdUMP forms a covalent ternary complex with TS, inhibiting the de novo synthesis of dTMP. Depletion of dTMP and then dTTP interferes with DNA synthesis and induces DNA strand breaks (Pagolotti et al., 1981; Lonn & Lonn, 1986; Yoshioka et al., 1987) . In addition, it has been shown that FUra can be incorporated into DNA, and this may also contribute to its cytotoxicity (Major et al., 1982; Sawyer et al., 1984) . Furthermore, FUra can be catabolised to H2FUra and consequently to FUPA and further to F-,-Ala.
We previously tried to determine the contribution of TS inhibition by FUra in PC-7/CDDP cells . However, there was no correlation between the level of TS inhibition revealed by 3H-FdUMP binding assay and sensitivity to FUra. These data suggest that the factors responsible for TS inhibition do not contribute to the collateral sensitivity of FUra. Therefore, we have examined the effects of FUra on RNA and dTTP pools to investigate further the underlying mechanisms responsible for the collateral sensitivity to FUra in PC-7/CDDP cells.
limiting-dilution technique (Hong et al., 1988; Ohe et al., 1990 ). Resistance to CDDP was stable for at least 6 months in CDDP-free medium. Prior to use for experiments, the cell lines were propagated by culturing them in RPMI 1640 medium supplemented with 10% heat-inactivated FBS (Immuno-Biochemical Laboratories, Fujioka, Japan), penicillin (100unitsml-') and streptomycin (100 gmlm'). and PC-7/CDDP cells were Colony-forming assay Colony-forming efficiency was assessed in a double-layer soft agar system as previously described (Ohe et al., 1989 (Ogur & Rosen, 1950 (Figure 2a) . We also measured the incorporation of FUra into the RNA fraction ( Figure 2b ). The incorporation of FUra into RNA was parallel with the total cellular accumulation in each cell line with approximately 50% of the total accumulation of FUra incorporated into RNA in each case. Corresponding to the inhibitory effect of Urd on FUra-induced cytotoxicity, the amount of FUra incorporated into RNA in PC-7/CDDP cells was 17% of that in PC-7 cells. We also measured the incorporation of FUra into the DNA fraction, but the amount incorporated was very small (less than 2% of the incorporation into the RNA fraction) in PC-7 cells and there was even less incorporation of radioactivity into DNA in PC-7/CDDP cells (Figure 2c ). To confirm the results on FUra-incorporation into RNA, the amounts of intracellular metabolites of FUra were measured by TLC (Figure 3) . Fluororibonucleotide (FUMP, FUDP, and FUTP) production in PC-7/CDDP cells was decreased to less than 18% of that in PC-7 cells. Although we could not separate the FUDP and FUTP in this TLC method, decreased production of FUTP in PC-7/CDDP cells was confirmed by a previously described HPLC method (Pagolotti et al., 1981) . FUTP production in PC-7/CDDP cells was about 30% of that in PC-7 cells (data not shown). FdUMP, which interacted with TS, was present at higher level in PC-7/CDDP cells than the fluoro-ribonucleotide, although the amount of FdUMP in PC-7/CDDP cells was 65% of that in PC-7 cells. There was no enhanced degrada- tion of FUra in PC-7/CDDP cells in comparison with that in PC-7 cells. These data show that the synthesis of fluororubinucleotides was decreased more than the synthesis of FdUMP in PC-7/CDDP cells.
Change of dTTP levels induced by FUra Inhibition of TS activity by FdUMP results in a reduction in dTTP levels (Yoshioka et al., 1987) . We did not, however, find enhanced inhibition of TS activity in PC-7/CDDP cells in our previous study; the free TS level was almost the same in both cell lines after 6 h FUra treatment (Ohe et al., 1990 ). In the present study, we measured the reduction in the dTTP level (Figure 4) . FUra produced greater reduction in dTTP level in CDDP-resistant cells after 6 h FUra treatment. This result is consistent with the fact that PC-7/CDDP cells showed collateral sensitivity to FUra.
DNA strand breaks in cells treated with FUra Several reports have described DNA strand breaks following a reduction in dTTP level (Yoshioka et al., 1987; Lonn & Lonn, 1986 . Therefore, we examined both cell lines for formation of DNA strand breaks by the alkaline elution techniques. More DNA single-strand breaks were observed in PC-7/CDDP cells ( Figure 5 ). These data suggest that the toxicity of FUra for PC-7/CDDP cells may be mainly due to the inhibition of synthesis of substrate for DNA replication. The degree of inhibition of TS activity is not correlated with the degree of reduction in dTTP level . genous 3H-dThd (50 nM) into DNA than PC-7 cells . Based on these data, we speculated that salvage synthesis of dTMP might be different in these cells, which could explain the greater reduction in dTTP levels in the PC-7/CDDP cells.
Short-term uptake of dThd Our previous study did not reveal a difference in dThd kinase activity, which catalyses phosphorylation of dThd . Therefore, we examined the membrane transport of dThd, the initial process of the dThd salvage pathway. Figure 6 shows short-term uptake of dThd at 25°C, demonstrated by the rapid sampling technique. Initial uptake of dThd by PC-7/CDDP cells was lower than that by PC-7 cells after treatment with 5 gM dThd (Figure 6a,b) . However, the amount of dThd taken up by PC-7/CDDP cells was close to that by the parental cells at a high concentration of dThd ( Figure 6b ). This phenomenon was consistent with the concentration-response of dThd-suppression of FUra-induced cytotoxicity seen in the colony-forming assay. In contrast, cellular uptake of FUra was at almost the same level in both cell lines, and the amount of FUra incorporated into the cells increased depending on the exogenous FUra concentration in the same manner in both cell lines (Figure 7a,b) . Under the conditions of the colony-forming assay, the concentration of dThd derived from serum is less than 1 g4M (Nottebrock & Then, 1977; Schaer et al., 1978; Sobrero & Bertino, 1986) . Therefore, decreased uptake of dThd may be responsible for the decreased dTTP production in PC-7/CDDP cells. We also determined the rate of dThd transport. As the process of dThd transport was very rapid at 25°C, we decreased the temperature to determine the initial rate of dThd uptake. Although the initial rate of dThd-uptake by PC-7/CDDP cells was also lower than that by PC-7 cells at 1 5C, the difference in dThd-uptake disappeared with the decrease in assay temperature (Figure 8a ). An inhibitor of facilitated diffusion of nucleoside, DP inhibited the dThd uptake by both cell lines to a similar extent (Figure 8b ). These data suggest that the factor associated with temperature-dependent and DP-insensitive transport of dThd may be different in PC-7/CDDP cells. A CDDP-resistant cell line, PC-7/CDDP showed collateral sensitivity to FUra. The same phenomenon was also seen in a CDDP-resistant subline of a human colon carcinoma cell line, BE cells (Fram et al., 1990) . There are no previous reports of mechanistic analyses of this phenomenon. Therefore, in the present study, we have investigated the possible mechanism of collateral sensitivity to FUra in PC-7/ CDDP cells. Analysis of cellular FUra metabolites demonstrated that ribonucleotide synthesis from FUra (FUMP, FUDP and FUTP) in PC-7/CDDP cells was decreased to less than 18% of that in PC-7 cells. The amount of FUra incorporated ;nto RNA of PC-7/CDDP cells was also decreased, to 17% of that in PC-7 cells. Urd prevented the cytotoxicity of FUra in PC-7 cells, but not in PC-7/CDDP cells. Thus, the collateral sensitivity of FUra in PC-7/CDDP cells cannot be explained by the effect of FUra on RNA. On the other hand, dThd prevented the cytotoxicity of FUra in both cell lines although there are the possible artefacts of testing TS inhibitors with reference to dThd protection (Jackman et al., 1984) . FdUMP was present at higher level in PC-7/CDDP cells than the fluoro-ribonucleotide (Figure 3) . These results suggest that FUra mainly inhibits DNA synthesis in PC-7/ CDDP cells. This conclusion was supported by the fact that leucovorin enhanced the cytotoxicity of FUra in PC-7/CDDP cells, but not in PC-7 cells. The decreased effect of FUra on RNA seem to contradict the enhanced sensitivity to FUra in PC-7/CDDP cells. However, the mechanism of action of FUra is very complex and it is still under question whether damage to DNA or to RNA can induce the greater cytotoxic effect.
The inhibitory effect of FUra on DNA synthesis has been hypothesised to result from inhibition of TS by FdUMP (Chabner, 1981; Heidelberger et al., 1983) . However, in our preliminary study, we did not see any enhancement of TS inhibition in PC-7/CDDP cells when determined by 3H- FdUMP binding assay . In the present study, we examined PC-7 and PC-7/CDDP cells for changes occurring after inhibition of TS by FdUMP. We found that FUra induced a greater reduction in dTTP pools and more single-strand breaks of DNA in PC-7/CDDP cells without the enhanced incorporation of FUra into DNA. After 6 h treatment with FUra, free TS was at almost the same level in PC-7 and PC-7/CDDP cells , while FUra induced greater reduction in the dTTP pool in PC-7/CDDP cells than in PC-7 cells. The same levels of cellular free TS could produce the same level of dTMP. Additionally, cellular dTTP levels in both cell lines were the same in the absence of FUra (Figure 4) . Accordingly, it is difficult to explain that greater reduction in the dTTP pool in PC-7/CDDP cells by FdUMP-mediated TS inhibition. It might also be possible to assume that the duration of TS inhibition was greater in PC-7/CDDP than in PC-7 cells since an in vivo study suggested the importance of the duration of TS inhibition (Houghton et al., 1986) . However, the greater reduction in the dTTP pool in PC-7/CDDP cells has already been observed after 6 h FUra treatment. Therefore, the duration of TS inhibition may not be an important factor in the mechanism of collateral sensitivity to FUra in PC-7/CDDP cells. Although the total TS content of PC-7/CDDP cells was 70% of that of PC-7 cells, Scanlon and Kashani-Sabet (1988) reported that a CDDP-resistant ovarian carcinoma cell line, A2780cP, exhibited a 3-fold increase in mRNA for TS and dihydrofolate reductase and a 2.5-fold increase in the activities of both enzymes compared with the parental cells. These CDDP-resistant A2780cP cells showed cross-resistance to FUra, FdUrd and methotrexate , Newman et al., 1988 . Teicher et al. (1986) reported that a CDDPresistant head and neck squamous cell carcinoma cell line (SCC-25/CP) showed cross-resistance to methotrexate, but not to FUra. In addition, Kikuchi et al. (1988) reported that a CDDP-resistant cell line, KFr, derived from human serous cystadenocarcinoma of the ovary, showed no cross-resistance to FUra. Accordingly, the determinants relating to the sensitivity or resistance to FUra in CDDP-resistant cell lines might differ with the cell line.
The greater reduction in dTTP pools in PC-7/CDDP cells suggests the decrease in capacity of dTTP synthesis by a non-TS mediated process. dTMP can be synthesised from dThd rather than from dUMP in de novo synthesis. Accordingly, another proposed determinant of dTTP production is the availability of dThd through the salvage pathway (Nottebrook & Then, 1977; Howell et al., 1978; Sobrero & Bertino, 1986) . We previously showed that less exogenous 3H-dThd (50 nM) was incorporated into DNA of PC-7/ CDDP cells than into that of PC-7 cells, without a significant difference in dThd kinase activity . Therefore, we examined the membrane transport of dThd, the initial process of the dThd salvage pathway. Short-term uptake of dThd was lower in PC-7/CDDP cells than in PC-7 cells. As shown in Figure 6a , it is clear that uptake of dThd was decreased in PC-7/CDDP cells. The uptake of dThd for 5 s does not mean the initial rate of dThd uptake because dThd uptake was saturated within 3 s at 25C. However, it is possible that the difference in dThd uptake for 5 s was reflected in the difference in the membrane transport of dThd since the rate of dThd uptake was low in the second phase as shown in the time course experiment. A decreased initial uptake of dThd in the linear phase was also observed in PC-7/CDDP cells at 15°C. As shown in Figure 6b , the difference in the dThd uptake between PC-7/CDDP and PC-7 was greater in the lower exogenous dThd concentrations at 25°C. This phenomenon is consistent with the concentration response of dThd suppression of FUra-induced cytotoxicity seen in the colony-forming assay. Lower concentrations of dhd (0.1 and 1 pM) did not modify the FUrainduced cytotoxicity in PC-7/CDDP cells, and higher concentrations (10 and 301LM) were necessary for the modification of the cytotoxicity (Table II) . These data clearly demonstrate that the rate of dThd uptake at a low concentration (1 !LM or less) is too low to support DNA replication in the absence of endogenous dTMP synthesis. Therefore, it is possible that FUra-induced cytotoxicity in PC-7/CDDP cells is associated with the inhibition of dTTP synthesis and that the decreased uptake of dThd is the mechanism of the collateral sensitivity to FUra in PC-7/CDDP cells.
Two dThd-membrane transport systems have been identified in mammalian cells (Belt, 1983;  Vijayalakshmi & Belt, 1988; Jarvis, 1989; Plagemann & Woffendin, 1989) . One is a symmetrical, non-concentrative and facilitated diffusion system with broad substrate specificity which has low affinity for dThd. The other is a sodium-and energy-dependent and concentrative transport system which has high affinity for dThd. It may be that the exogenous dThd passes through the cell membrane mainly by the high-affinity transporter in our culture condition. In addition, further analysis of dThdmembrane transport showed that the difference in the levels of dThd uptake disappeared at low temperature and an inhibitor of facilitated diffusion, DP, inhibited dThd uptake in PC-7/CDDP and PC-7 cells to a similar extent. Another inhibitor, 6-[(4-nitrobenzyl)thio]-9-p-D-ribofurasylpurine also inhibited dThd uptake by both cell line (data not shown). These data suggest that a dThd-transporter sensitive to these inhibitors exists not only in PC-7 cells but also in PC-7/ CDDP cells. Therefore, we now hypothesise that the decreased uptake of dThd is related to the difference in the energy-dependent transport of dThd. However, more detailed analysis is required to elucidate the mechanisms of the decreased uptake of dThd in PC-7/CDDP cells.
Recently, there have been many studies that demonstrate a qualitative inverse relationship between drug sensitivity to CDDP and total intracellular CDDP concentration in many CDDP-resistant cell lines, exceptions to which include A2780cP cells (Richon et al., 1987; Waund, 1987; Andrews et al., 1988; Hospers et al., 1988; Kraker & Moore, 1988; Kuppen et al., 1988; Newman et al., 1988; Bungo et al., 1990; Fujiwara et al., 1990) . Interestingly, the accumulation of CDDP in PC-7/CDDP cells was 30% of that in PC-7 cells (unpublished data). Although CDDP is believed to enter cells by passive diffusion, an energy-dependent CDDP accumulation mechanism has been demonstrated (Andrews et al., 1988) . It has also been suggested that alteration in drug uptake might be one of the simplest and earliest events leading to CDDP resistance (Richon et al., 1987) . These findings further suggest a possibility that the decreased uptake of dThd is associated with the decreased uptake of CDDP in PC-7/CDDP cells. Although the mechanisms underlying the decreased uptake are still unclear, we speculate that common changed process(es) exist in CDDP and dThd uptake. The possibility of such factors related to uptake of CDDP and dThd warrants further study in order to clarify the mechanisms of drug resistance.
